TRACY OSBORNE: Open Payments
NPI 1902268998 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 53 payments from 19 companies in 2025. Trend: 2023 $224 · 2024 $1,813 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $384 |
| Madrigal Pharmaceuticals | 4 | $198 |
| Exact Sciences Corporation | 3 | $62 |
| Novo Nordisk Inc | 3 | $61 |
| QOL Medical, LLC | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ardelyx, Inc. | 3 | $54 |
| Abbott Laboratories | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: REZDIFFRA, SKYRIZI, LINZESS, RINVOQ, CREON, Wegovy, Sucraid, IBSRELA.
Industry payments across FL — which companies pay providers there.
